A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene

Analytical Biochemistry

Volumn 353, Issue 2, 2006, Pages 226-235

  Lucarelli, Marco ^a   Narzi, Lorena ^a   Piergentili, Rita ^a   Ferraguti, Giampiero ^a   Grandoni, Francesco ^a   Quattrucci, Serena ^a   Strom, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CFTR; Cystic fibrosis; Extended sequencing; High sensitivity mutational analysis

Indexed keywords

GENES; PURIFICATION; SENSITIVITY ANALYSIS;

CFTR; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS; DIAGNOSTIC METHODS; EXON/INTRON BOUNDARIES; EXTENDED SEQUENCING; GENOTYPIC CHARACTERIZATION; MUTATIONAL ANALYSIS;

DIAGNOSIS;

ALKALINE PHOSPHATASE; EXONUCLEASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CAPILLARY ELECTROPHORESIS; CYSTIC FIBROSIS; DNA EXTRACTION; EXON; GENE; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; INTRON; MUTATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TECHNIQUE;

EID: 33747198839     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.03.022     Document Type: Article

References (40)

1. Consortium for CF Genetic Analysis, www.genet.sickkids.on.ca/cftr/.
2. Merlo C.A., and Boyle M.P. Modifier genes in cystic fibrosis lung disease. J. Lab. Clin. Med. 141 (2003) 237-241
3. Salvatore F., Scudiero O., and Castaldo G. Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes. Am. J. Med. Genet. 111 (2002) 88-95
4. Sagel S.D., and Accurso F.J. Monitoring inflammation in CF: Cytokines. Clin. Rev. Allergy Immunol. 23 (2002) 41-57
5. Acton J.D., and Wilmott R.W. Phenotype of CF and the effects of possible modifier genes. Paediatr. Respir. Rev. 2 (2001) 332-339
6. Drumm M.L. Modifier genes and variation in cystic fibrosis. Respir. Res. 2 (2001) 125-128
7. Rowntree R.K., and Harris A. The phenotypic consequences of CFTR mutations. Ann. Hum. Genet. 67 (2003) 471-485
8. McKone E.F., Emerson S.S., Edwards K.L., and Aitken M.L. Effect of genotype on phenotype and mortality in cystic fibrosis: A retrospective cohort study. Lancet 361 (2003) 1671-1676
9. Noone P.G., and Knowles M.R. "CFTR-opathies": Disease phenotype associated with cystic fibrosis transmembrane regulator gene mutations. Respir. Res. 2 (2001) 328-332
10. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 67 (2000) 117-133
11. Estivill X. Complexity in a monogenic disease. Nat. Genet. 12 (1996) 348-350
12. Ferec C., Le Marechal C., Audrezet M.P., Farinha C.M., Amaral M.D., Gallati S., Sanz J., Steiner B., Mouchel N., Harris A., and Schwarz M.J. Analysis of genomic CFTR DNA. J. Cystic Fibrosis 3 Suppl. 2 (2004) 7-10
13. Fanen P., Ghanem N., Vidaud M., Besmond C., Martin J., Costes B., Plassa F., and Goossens M. Molecular characterization of cystic fibrosis: Sixteen novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 13 (1992) 770-776
14. Costes B., Fanen P., Goossens M., and Ghanem N. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum. Mutat. 2 (1993) 185-191
15. Wallace A.J. SSCP/Heteroduplex analysis. Methods Mol. Biol. 187 (2002) 151-163
16. Ravnik-Glavac M., Glavac D., and Dean M. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum. Mol. Genet. 3 (1994) 801-807
17. Ravnik-Glavac M., Glavac D., Chernick M., di Sant'Agnese P., and Dean M. Screening for CF mutations in adult cystic fibrosis patients with a directed and optimized SSCP strategy. Hum. Mutat. 3 (1994) 231-238
18. D'Apice M.R., Gambardella S., Bengala M., Russo S., Nardone A.M., Lucidi V., Sangiuolo F., and Novelli G. Molecular analysis using DHPLC of cystic fibrosis: Increase of the mutation detection rate among the affected population in central Italy. BMC Med. Genet. 5 (2004) 8
19. Ravnik-Glavac M., Atkinson A., Glavac D., and Dean M. DHPLC screening of cystic fibrosis gene mutation. Hum. Mutat. 19 (2002) 374-383
20. Le Marechal C., Audrezet M.P., Quere I., Raguenes O., Lagonne S., and Ferec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): Major implications for genetic counseling. Hum. Genet. 108 (2001) 290-298
21. Grossman P.D., Bloch W., Brinson E., Chang C.C., Eggerding F.A., Fung S., Iovannisci D.M., Woo S., and Winn-Deen E.S. High density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res. 22 (1994) 4527-4534
22. Rendine S., Calafell F., Cappello N., Gagliardini R., Caramia G., Rigillo N., et al. Genetic history of cystic fibrosis mutations in Italy: I. Regional distribution. Ann. Hum. Genet. 61 (1997) 411-424
23. Gibson L.E., and Cooke R.E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23 (1959) 545-549
24. DelMar E.G., Largman C., Brodrick J.W., and Geokas M.C. A sensitive new substrate for chymotrypsin. Anal. Biochem. 99 (1979) 316
25. Stein J., Jung M., Sziegoleit A., Zeuzem S., Caspary W.F., and Lembcke B. Fecal immunoreactive elastase-1: evaluation of new tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Clin. Chem. 42 (1996) 222-226
26. Walters M.P., Kelleher J., Gilbert J., and Littlewood J.M. Clinical monitoring of steatorrhea in cystic fibrosis. Arch. Dis. Child. 65 (1990) 913
27. Zielenski J., Rozmahel R., Bozon D., Kerem B.-S., Grzelczak Z., Riordan J.R., Rommens J., and Tsui L.-C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10 (1991) 214-228
28. Chu C.-S., Trapnell B.-C., Murtagh Jr. J.J., Moss J., Dalemans W., Jallat S., Mercenier A., Pavirani A., Lecocq J.P., and Cutting G.R. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J. 10 (1991) 1355-1363
29. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
30. Narzi L., Lucarelli M., Lelli A., Grandoni F., Lo Cicero S., Ferraro A., Matarazzo P., Delaroche I., Quattrucci S., Strom R., and Antonelli M. Comparison of two different protocols of neonatal screening for cystic fibrosis. Clin. Genet. 62 (2002) 245-249
31. Rommens J.M., Iannuzzi M.C., Kerem B.-S., Drumm M.L., Melmer G., Dean M., Rozmahel R., Cole J.L., Kennedy D., Hidaka N., Zsiga M., Buchwald M., Riordan J.R., Tsui L.C., and Collins F.S. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245 (1989) 1059-1065
32. Savov A., Jordanova A., Gavrilov D., Angelicheva D., and Kalaydjieva L. G1244V: A novel missense mutation in exon 20 of the CFTR gene in a Bulgarian cystic fibrosis patient. Hum. Mol. Genet. 3 (1994) 513-514
33. Devoto M., Ronchetto P., Fanen P., Orriols J.J., Romeo G., Goossens M., Ferrari M., Magnani C., Seia M., and Cremonesi L. Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am. J. Hum. Genet. 48 (1991) 1127-1132
34. Feldmann D., Couderc R., Audrezet M.-P., Ferec C., Bienvenu T., Desgeorges M., Claustres M., Mittre H., Blayau M., Bozon D., Malinge M.C., Monnier N., Bonnefont J.P., Iron A., Bieth E., Dumur V., Clavel C., Cazeneuve C., and Girodon E. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum. Mutat. 22 (2003) 340
35. Liang M.-H., Wertz K.K., Bowman C.M., Hsu E., Shapiro B., and Wong L.-J.C. 3849 + 10 kb C-> T splicing mutation in Hispanic CF patients. Mol. Genet. Metab. 64 (1998) 213-216
36. Chiba-Falek O., Kerem E., Shoshani T., Aviram M., Augarten A., Bentur L., Tal A., Tullis E., Rahat A., and Kerem B. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849 + 10 kb C->T mutation. Genomics 53 (1998) 276-283
37. Stern R.C., Doershuk C.F., and Drumm M.L. 3849 + 10 kb C->T mutation and disease severity in cystic fibrosis. Lancet 346 (1995) 274-276
38. Highsmith W.E., Burch L.H., Zhou Z., Olsen J.C., Boat T.E., Spock A., Gorvoy J.D., Quittell L., Friedman K.J., Silverman L.M., Boucher R.C., and Knowles M.R. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331 (1994) 974-980
39. Padoan R., Bassotti A., Seia M., and Corbetta C. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Eur. J. Pediatr. 161 (2002) 212-215
40. n tract length in CFTR gene. BioTechniques 32 (2002) 540-547